Matthew J. Shattock - 31 Mar 2023 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2023, 16:17:30 UTC
Previous filing
14 Nov 2023
Next filing
31 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +73 +0.78% $0.000000 9,412 10 Feb 2023 Common Stock 73 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +439 +4.7% $0.000000 9,852 31 Mar 2023 Common Stock 439 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.